Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
Nonalcoholic fatty liver disease is the leading cause of liver disease in western society. It is a cause of end-stage liver disease, with increased mortality secondary to cirrhosis and its complications. It is also recognized that cardiovascular disease is a significant cause of death in these patie...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/2012/725468 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832567681144848384 |
|---|---|
| author | Melanie D Beaton |
| author_facet | Melanie D Beaton |
| author_sort | Melanie D Beaton |
| collection | DOAJ |
| description | Nonalcoholic fatty liver disease is the leading cause of liver disease in western society. It is a cause of end-stage liver disease, with increased mortality secondary to cirrhosis and its complications. It is also recognized that cardiovascular disease is a significant cause of death in these patients. Significant work evaluating various treatments has been performed in recent years; however, to date, no ideal therapy exists. Lifestyle modification remains the cornerstone of management. The present article reviews the current status of various treatment modalities evaluated in nonalcoholic fatty liver disease. |
| format | Article |
| id | doaj-art-b8b3a6f7002e4933a793e44adde3d86e |
| institution | Kabale University |
| issn | 0835-7900 |
| language | English |
| publishDate | 2012-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology |
| spelling | doaj-art-b8b3a6f7002e4933a793e44adde3d86e2025-02-03T01:00:56ZengWileyCanadian Journal of Gastroenterology0835-79002012-01-0126635335710.1155/2012/725468Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic SteatohepatitisMelanie D Beaton0Department of Medicine, Division of Gastroenterology, University of Western Ontario, London, Ontario, CanadaNonalcoholic fatty liver disease is the leading cause of liver disease in western society. It is a cause of end-stage liver disease, with increased mortality secondary to cirrhosis and its complications. It is also recognized that cardiovascular disease is a significant cause of death in these patients. Significant work evaluating various treatments has been performed in recent years; however, to date, no ideal therapy exists. Lifestyle modification remains the cornerstone of management. The present article reviews the current status of various treatment modalities evaluated in nonalcoholic fatty liver disease.http://dx.doi.org/10.1155/2012/725468 |
| spellingShingle | Melanie D Beaton Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Canadian Journal of Gastroenterology |
| title | Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis |
| title_full | Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis |
| title_fullStr | Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis |
| title_full_unstemmed | Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis |
| title_short | Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis |
| title_sort | current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis |
| url | http://dx.doi.org/10.1155/2012/725468 |
| work_keys_str_mv | AT melaniedbeaton currenttreatmentoptionsfornonalcoholicfattyliverdiseaseandnonalcoholicsteatohepatitis |